Clinical Trials Logo

Clinical Trial Summary

Pyridostigmine is a medication that is used in certain heart rate and blood pressure conditions. This medication, as a side effect, is known to also cause changes in the junction between a nerve and muscle. The changes caused at the nerve muscle junction by pyridostigmine could alter the effect of muscle relaxants (a medication used during surgery and anesthesia). The investigators are conducting this study to see whether patients taking pyridostigmine are more or less sensitive to rocuronium (a muscle relaxing medication used during surgery).


Clinical Trial Description

No subjects enrolled. No data collected. ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02157545
Study type Observational
Source University of Toledo Health Science Campus
Contact
Status Withdrawn
Phase Phase 4
Start date March 2014
Completion date May 2016

See also
  Status Clinical Trial Phase
Completed NCT02696837 - Pediatric Inguinal Hernia Repair: Are Muscle Relaxants Necessary? Endotracheal Intubation vs Laryngeal Mask Airway N/A
Enrolling by invitation NCT02467595 - The Effect of no Muscle Relaxant Versus Reduced-dose Rocuronium on Anesthesia in Adenotonsillectomy Phase 4
Completed NCT02425449 - Fade Upon TOF Stimulation Induced by Succinylcholine Phase 4